Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. 2007

Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
Global Pharmaceutical Research and Development, Antiviral Research, Abbott Laboratories, 200 Abbott Park Road, Abbott Park, IL 60064, USA. teresa.ng@abbott.com

Hepatitis C virus (HCV) replication is highly dependent on host cell factors. Identification of these host factors not only facilitates understanding of the biology of HCV infection but also enables the discovery of novel targets for anti-HCV therapy. To identify host genes important for HCV RNA replication, we screened a library of small interfering RNA (siRNA) that targets approximately 4,000 human genes in Huh7-derived EN5-3 cells harboring an HCV subgenomic replicon with the nonstructural region NS3-NS5B from the 1b-N strain. Nine cellular genes that potentially regulate HCV replication were identified in this screen. Silencing of these genes resulted in inhibition of HCV replication by more than 60% and exhibited minimal toxicity. Knockdown of host gene expression by these siRNAs was confirmed at the RNA level and, in some instances, at the protein level. The level of siRNA silencing of these host genes correlated well with inhibition of HCV. These genes included those that encoded a G-protein coupled receptor (TBXA2R), a membrane protein (LTbeta), an adapter protein (TRAF2), 2 transcription factors (RelA and NFkappaB2), 2 protein kinases (MKK7 and SNARK), and 2 closely related transporter proteins (SLC12A4 and SLC12A5). Of interest, some of these genes are members of the tumor necrosis factor/lymphotoxin signaling pathway. CONCLUSIONS Findings of this study may provide important information for understanding HCV replication. In addition, these cellular genes may constitute a novel set of targets for HCV antiviral therapy.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015723 Gene Library A large collection of DNA fragments cloned (CLONING, MOLECULAR) from a given organism, tissue, organ, or cell type. It may contain complete genomic sequences (GENOMIC LIBRARY) or complementary DNA sequences, the latter being formed from messenger RNA and lacking intron sequences. DNA Library,cDNA Library,DNA Libraries,Gene Libraries,Libraries, DNA,Libraries, Gene,Libraries, cDNA,Library, DNA,Library, Gene,Library, cDNA,cDNA Libraries
D015967 Gene Expression Regulation, Viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Regulation of Gene Expression, Viral,Viral Gene Expression Regulation,Regulation, Gene Expression, Viral
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
January 2007, Archives of virology,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
June 2004, Virus research,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
November 2011, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
January 2008, The Journal of biological chemistry,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
April 2009, Virology,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
February 2003, Proceedings of the National Academy of Sciences of the United States of America,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
April 2004, Journal of virology,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
November 2003, Molecular therapy : the journal of the American Society of Gene Therapy,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
January 2007, Reviews in medical virology,
Teresa I Ng, and Hongmei Mo, and Tami Pilot-Matias, and Yupeng He, and Gennadiy Koev, and Preethi Krishnan, and Rubina Mondal, and Ron Pithawalla, and Wenping He, and Tanya Dekhtyar, and Jeremy Packer, and Mark Schurdak, and Akhteruzzaman Molla
October 2007, RNA (New York, N.Y.),
Copied contents to your clipboard!